Thrombotic events were 8.2% and 6.7% in the high vs low-dose groups, respectively (OR 0.8; 95% CI 0.08-8.2, P = 0.87). No statistically significant differences were found in secondary outcomes. Conclusion: In patients with FXa inhibitor-associated ICH, high-dose 4FPCC was associated with increased odds of hemostasis achievement. There was no
Jun 10, 2013 · Grade 3 or Grade 4 complications of oral cancer treated with LDR vs. HDR brachytherapy. It was estimated that 128,000 people worldwide died from oral cavity cancer (including lip cancer) in 2008 . The mortality of oral cancer varies geographically, about 3–4 per 100,000 for men and 1.5–2.0 per 100,000 for women for most countries . 1zuOHvg.